1. Home
  2. VVOS vs GDTC Comparison

VVOS vs GDTC Comparison

Compare VVOS & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.26

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$1.39

Market Cap

16.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VVOS
GDTC
Founded
2016
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
16.0M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
VVOS
GDTC
Price
$2.26
$1.39
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
129.8K
27.3K
Earning Date
11-19-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,317,000.00
$573,193.00
Revenue This Year
$17.96
$5.37
Revenue Next Year
$55.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.76
63.03
52 Week Low
$1.93
$1.29
52 Week High
$7.95
$3.68

Technical Indicators

Market Signals
Indicator
VVOS
GDTC
Relative Strength Index (RSI) 51.67 35.87
Support Level $1.94 $1.29
Resistance Level $2.69 $1.43
Average True Range (ATR) 0.14 0.10
MACD 0.06 0.00
Stochastic Oscillator 41.18 25.43

Price Performance

Historical Comparison
VVOS
GDTC

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: